 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Geron Corporation
 |
Geron Corporation |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Patents seen complicating stem cell research Aug 22 2001 12:43 PM PDT
U.S. government holds talks on stem cell access Aug 21 2001 02:00 PM PDT
US stock index futures end modestly up, await Fed Aug 20 2001 02:08 PM PDT
Covad Posts Second-Quarter Loss Aug 20 2001 02:07 PM PDT
Volkswagen Mexico strike continues amid wage talks Aug 20 2001 12:38 PM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
A Cure for the Blackout Blues
Feb 12 2001 12:00 AM PST
PROFILE |
 |
Geron is no codger. The firm, which gets its name from the Greek word for "old man," focuses on telomeres, structures that act as a molecular clock for cellular aging, and telomerase, an enzyme that may prolong cellular life. Geron hopes to make cancer cells age and die or fight Parkinson's, liver, heart, and other degenerative diseases by turning back the cellular clock. With the Roslin Institute (co-creators of Dolly the cloned sheep), the firm is studying how to use genetically modified pigs as sources for human organ transplants. Geron is also working with Celera Genomics to develop stem cells for a variety of medical purposes, as well as with Merix Bioscience to develop telomerase-based cancer vaccines.
COMPETITION |
 |
Nexell Therapeutics Inc. (NEXL)
PPL Therapeutics plc (PPL)
SUGEN, Inc. (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 6.60
1-Yr. Sales Growth: 22.2%
Employees: 112
Revenue per employee: $58,928.57
KEY PEOPLE |
 |
Thomas B. Okarma
CEO
David L. Greenwood
CFO
CONTACT INFO |
 |
230 Constitution Dr.
Menlo Park, CA 94025
US
Phone: 650-473-7700
Fax: 650-473-7750
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |